Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography

Objectives: There is an overlap regarding Pittsburgh compound B (PIB) retention in patients clinically diagnosed as Alzheimer's disease (AD) and non-AD dementia. The aim of the present study was to investigate whether there are any differences between PIB-positive and PIB-negative patients in a...

Full description

Bibliographic Details
Main Authors: M. Degerman Gunnarsson, M. Lindau, A.F. Santillo, A. Wall, H. Engler, L. Lannfelt, H. Basun, L. Kilander
Format: Article
Language:English
Published: Karger Publishers 2013-12-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Alzheimer’s disease
Dementia with Lewy bodies
Frontotemporal dementia
β-Amyloid
Amyloid biomarker
Pittsburgh compound B positron emission tomography
[18F]Fluoro-2-deoxy-D-glucose positron emission tomography
Neuropsychological tests
Trail Making Test, part A
Episodic memory
Online Access:http://www.karger.com/Article/FullText/356273

Internet

http://www.karger.com/Article/FullText/356273

Similar Items